These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 29568881
1. Liraglutide improves hepatic insulin resistance via the canonical Wnt signaling pathway. Qin Y, Chen M, Yang Y, Zhou XR, Shao SY, Wang DW, Yuan G. Mol Med Rep; 2018 May; 17(5):7372-7380. PubMed ID: 29568881 [Abstract] [Full Text] [Related]
2. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. Liu TY, Shi CX, Gao R, Sun HJ, Xiong XQ, Ding L, Chen Q, Li YH, Wang JJ, Kang YM, Zhu GQ. Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094 [Abstract] [Full Text] [Related]
4. Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway. Wu YR, Shi XY, Ma CY, Zhang Y, Xu RX, Li JJ. Cardiovasc Diabetol; 2019 Nov 09; 18(1):146. PubMed ID: 31706303 [Abstract] [Full Text] [Related]
6. Liraglutide Attenuates Hepatic Oxidative Stress, Inflammation, and Apoptosis in Streptozotocin-Induced Diabetic Mice by Modulating the Wnt/β-Catenin Signaling Pathway. Yu J, Zhao Y, Xu L, Li W, Zhang H, Ping F, Li Y. Mediators Inflamm; 2023 Nov 09; 2023():8974960. PubMed ID: 36756089 [Abstract] [Full Text] [Related]
7. Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in diabetic KKAy mice. Chen LN, Lyu J, Yang XF, Ji WJ, Yuan BX, Chen MX, Ma X, Wang B. Int J Mol Med; 2013 Oct 09; 32(4):892-900. PubMed ID: 23877319 [Abstract] [Full Text] [Related]
10. Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output. Liu J, Yang K, Yang J, Xiao W, Le Y, Yu F, Gu L, Lang S, Tian Q, Jin T, Wei R, Hong T. EBioMedicine; 2019 Mar 09; 41():73-84. PubMed ID: 30827929 [Abstract] [Full Text] [Related]
11. GLP-1 promotes osteogenic differentiation of human ADSCs via the Wnt/GSK-3β/β-catenin pathway. Li Y, Fu H, Wang H, Luo S, Wang L, Chen J, Lu H. Mol Cell Endocrinol; 2020 Sep 15; 515():110921. PubMed ID: 32615283 [Abstract] [Full Text] [Related]
14. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease. Gao H, Zeng Z, Zhang H, Zhou X, Guan L, Deng W, Xu L. Biol Pharm Bull; 2015 Sep 15; 38(5):694-702. PubMed ID: 25947915 [Abstract] [Full Text] [Related]
15. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. Xia X, Yan J, Shen Y, Tang K, Yin J, Zhang Y, Yang D, Liang H, Ye J, Weng J. PLoS One; 2011 Feb 03; 6(2):e16556. PubMed ID: 21304897 [Abstract] [Full Text] [Related]
19. Reduced expression of ERp46 under diabetic conditions in β-cells and the effect of liraglutide. Lampropoulou E, Lymperopoulou A, Charonis A. Metabolism; 2016 Jan 15; 65(1):7-15. PubMed ID: 26683792 [Abstract] [Full Text] [Related]